Pharmaceutical sciences

Neurogastrx Announces Agreement with Daewoong Pharmaceutical to Develop Fexuprazan for Treatment of Acid-Related GI Disorders in the U.S.

Retrieved on: 
Tuesday, June 8, 2021
Health sciences, Pharmaceutical sciences, Health care, Daewoong Pharmaceutical, Pharmaceutical industry, Medication

"This agreement bolsters our mission to advance transformative therapeutics for GI disorders with significant unmet need and disease burden.

Key Points: 
  • "This agreement bolsters our mission to advance transformative therapeutics for GI disorders with significant unmet need and disease burden.
  • We look forward to working with Daewoong Pharmaceutical as we develop fexuprazan for the U.S. and Canada."
  • "We are excited about fexuprazan and its potential to become an improved treatment option for patients with acid-related diseases," said Seng-Ho Jeon, Chief Executive Officer & President, Daewoong Pharmaceutical.
  • "We are delighted to enter into this strategic alliance with Neurogastrx as part of our plan to develop fexuprazan into a global product."

Structure-Based Virtual Screening Heating up AI in Drug Discovery Market, Finds IDTechEx

Retrieved on: 
Tuesday, June 8, 2021
Health sciences, Pharmaceutical sciences, Drug discovery, Natural sciences, Pharmaceutics, Bioinformatics, Cheminformatics, Alternatives to animal testing, Virtual screening

AI has been successfully applied to speed up virtual screening, de novo drug discovery, and can be utilized to optimize compounds to have drug-like properties.

Key Points: 
  • AI has been successfully applied to speed up virtual screening, de novo drug discovery, and can be utilized to optimize compounds to have drug-like properties.
  • IDTechEx's latest report, " AI in Drug Discovery 2021: Players, Technologies, and Applications ", covers AI technologies, including a discussion of architectures and algorithms used in the drug discovery process.
  • Aspects of the drug discovery process discussed include structure-based virtual screening, ligand-based virtual screening, phenotypic virtual screening, de novo drug discovery, lead optimization, and chemical synthesis planning.
  • IDTechEx finds that AI in structure-based virtual screening is receiving significant attention from investors.Source: IDTechEx Research
    For each segment of the drug discovery process covered in the report, IDTechEx analyzes key players, the capabilities of their software, technology readiness, and the progress of candidates to market.

3Brain AG CorePlate™ technology combines microchips and AI in a revolutionary new approach to drug discovery

Retrieved on: 
Tuesday, June 8, 2021
Health sciences, Branches of biology, Pharmaceutical sciences, Pharmaceutical industry, Electrophysiology, Microelectrode array, Neurophysiology, Physiology, MEA, Medication, Drug discovery

3Brain AG unveils groundbreaking CorePlatetechnology to allow the harvesting of big data on drug candidates before testing on humans to increase the chance of pharmaceutical success.

Key Points: 
  • 3Brain AG unveils groundbreaking CorePlatetechnology to allow the harvesting of big data on drug candidates before testing on humans to increase the chance of pharmaceutical success.
  • The CorePlate technology devised by 3Brain disrupts this paradigm by bringing the processing unit in contact with the cells.
  • With the CorePlate technology, pharmaceutical companies can save time and money by better filtering and prioritizing drug candidates.
  • After being the first to introduce CMOS-based HD-MEA (high-density microelectrode array), 3Brain is now setting up the next standard with the mentioned CorePlate technology.

Tryp Therapeutics to Present at the Ladenburg Thalmann Healthcare Conference

Retrieved on: 
Tuesday, June 8, 2021
Health sciences, Pharmaceutical sciences, Life sciences, Pharmaceutical industry, Pharmacology, Pharmacy, Medication

San Diego, California--(Newsfile Corp. - June 8, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) ("Tryp"), a pharmaceutical company focused on developing compounds for diseases with unmet medical needs through accelerated regulatory pathways, announced today that it is presenting at the Ladenburg Thalmann Healthcare Conference.

Key Points: 
  • San Diego, California--(Newsfile Corp. - June 8, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) ("Tryp"), a pharmaceutical company focused on developing compounds for diseases with unmet medical needs through accelerated regulatory pathways, announced today that it is presenting at the Ladenburg Thalmann Healthcare Conference.
  • Details of the presentation are as follows:
    Tryp Therapeutics is a pharmaceutical company focused on developing compounds for the treatment of diseases with unmet medical needs through accelerated regulatory pathways.
  • In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking information.
  • These factors are not intended to represent a complete list of the factors that could affect Tryp; however, these factors should be considered carefully.

MainStem, the Cannabis eCommerce Marketplace, Incorporates Industry's First End-to-End Purchasing Platform

Retrieved on: 
Monday, June 7, 2021
Health sciences, Medicine, Pharmaceutical sciences, Cannabis industry, Medical cannabis

Purchase Pro leverages the purchasing power of Marketplace, MainStem's established ecommerce platform, and streamlines all associated purchase data into a centralized hub for its users - cannabis companies ranging in size from small start-ups to the largest operators in North America.

Key Points: 
  • Purchase Pro leverages the purchasing power of Marketplace, MainStem's established ecommerce platform, and streamlines all associated purchase data into a centralized hub for its users - cannabis companies ranging in size from small start-ups to the largest operators in North America.
  • The incorporation of SaaS Purchase Pro into MainStem's ecommerce platform - the first combination of its kind in the cannabis industry - has already proven its value to operators of all sizes.
  • According to cannabis sales data platform BDSA, legal cannabis sales in the U.S. hit $17.5B in 2020, a 46% increase over 2019.
  • MainStem, the leading B2B ecommerce marketplace and integrated supply purchasing platform for cannabis companies, was founded in Seattle, Washington in 2014.

4Cable TV International, Inc. Announces:

Retrieved on: 
Monday, June 7, 2021
Medicinal plants, Herbs, Health sciences, Medicine, Pharmaceutical sciences, Cannabis, Entheogens, Euphoriants, Medical cannabis, Hemp

( https://www.instagram.com/CIGNFARM/ ) While the flower is drying, curing, and getting ready for sale, CIGN launches its Second Edition of the UPICK Hemp Weekend.

Key Points: 
  • ( https://www.instagram.com/CIGNFARM/ ) While the flower is drying, curing, and getting ready for sale, CIGN launches its Second Edition of the UPICK Hemp Weekend.
  • CIGN wishes to invite all shareholders and the public to attend on June 12 and 13.
  • 4Cable TV International, Inc. (OTC: CATV) seeks to create and operate a fully integrated global cannabis business, ranging from growing to retailing.
  • Statements in this press release regarding 4Cable TV International's business that are not historical facts are "forward-looking statements."

Put Canadians First by Suspending the Implementation of Harmful Drug Pricing Regulations

Retrieved on: 
Friday, June 4, 2021
Health sciences, Life sciences, Pharmaceutical sciences, Pharmaceutical industry, Pharmacology, Pharmacy, Medication

Policy decisions should be based on the value medicines and vaccines bring to Canadians, as well as fair and accurate reporting on patented medicine pricing.

Key Points: 
  • Policy decisions should be based on the value medicines and vaccines bring to Canadians, as well as fair and accurate reporting on patented medicine pricing.
  • To view an enhanced version of this graphic, please visit:
    Innovative Medicines Canada is the national association representing the voice of Canada's innovative pharmaceutical industry.
  • The association represents 47 companies who invest nearly $1.2-billion in R&D annually, fueling Canada's knowledge-based economy, while contributing $8-billion to Canada's economy.
  • Guided by the Code of Ethical Practices, all members work with governments, private payers, healthcare professionals, and stakeholders in a highly ethical manner.

Global Pharma Handbook 2021: Statistics, Information and Analysis on Prescription Drug Business and Regulatory Environments - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 3, 2021
Health, Pharmaceutical, Health sciences, Pharma, Pharmaceutical sciences, Health care, Pharmaceutical industry

The "Global Pharma Handbook 2021" directory has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Pharma Handbook 2021" directory has been added to ResearchAndMarkets.com's offering.
  • The Global Pharma Handbook 2021 provides pharmaceutical industry decision makers with a single source of accurate, up to date statistics, information and analysis on prescription drug business and regulatory environments throughout the world.
  • Coverage of over 70 individual countries (cumulatively representing more than 98% of global sales) and a summary section on the EU are included.
  • Company executives, consultants, marketing and licensing partners, policy makers, researchers, investors, reporters and others who work with the pharmaceutical industry will benefit from the Global Pharma Handbook.

SugarTop Buddery Enters Co-Branding Agreement with AgTech Company Terra Vera to Bring Pesticide-Free Cannabis to Oregon

Retrieved on: 
Thursday, June 3, 2021
Retail, Technology, Marketing, Communications, Other Consumer, Women, Environment, Other Retail, MEN, Agriculture, Natural Resources, Other Technology, Specialty, Science, Other Science, Consumer, Herbalism, Medicinal plants, Health sciences, Cannabis, Cannabis smoking, Entheogens, Medical cannabis, Branches of biology, Pharmaceutical sciences

Oregon cannabis consumers will soon find the array of premium SugarTop Buddery flower strains, as well as pre-rolls, treated by Terra Vera proudly labeled in licensed dispensaries across the state.

Key Points: 
  • Oregon cannabis consumers will soon find the array of premium SugarTop Buddery flower strains, as well as pre-rolls, treated by Terra Vera proudly labeled in licensed dispensaries across the state.
  • By co-branding with Terra Vera, we aim to further strengthen our consumers confidence in the quality and purity of our products, said SugarTop Buddery CEO and Co-founder Anna Kaplan.
  • We pride ourselves on transparency and hope these co-branded products help raise the bar for the licensed cannabis industry in Oregon and beyond.
  • The partnership with SugarTop Buddery also marks the debut of Terra Veras technology and services to Oregons licensed cannabis market.

European Union and USA Veterinary Drug Development Online Training Course, June 21-25, 2021 - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 3, 2021
Health, Consumer, Practice Management, Pets, Pharmaceutical, Veterinary, Health sciences, Life sciences, Pharmaceutical industry, Pharmaceutical sciences, Pharmacy, Medication, Pharmacology, Drug development

The "Working Through Veterinary Drug Development in the EU (European Union) and USA Training Course" conference has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Working Through Veterinary Drug Development in the EU (European Union) and USA Training Course" conference has been added to ResearchAndMarkets.com's offering.
  • This intensive five-day course provides a thorough understanding of how to develop a veterinary medicine in the EU and USA.
  • Presentations will cover pharmaceutical and process development, toxicological, pharmacological, residues and environmental studies, safety risk assessments, clinical development, regulatory and marketing input and project management.
  • Previous delegates who have benefited from this course include clinical scientists, pharmaceutical scientists, marketing managers and personnel from regulatory affairs, R&D and development.